BAJAJ BROKING

Notification
No new Notification messages
Wagons Learning IPO is Open!
Apply for the Wagons Learning IPO through UPI in just minutes.
Open a Free Demat Account
Pay ZERO maintenance charges for the first year, get free stock picks daily, and more.
Trade Now, Pay Later with up to 4x
Never miss a good trading opportunity due to low funds with our MTF feature.
Track Market Movers Instantly
Stay updated with real-time data. Get insights at your fingertips.

11817

532637

MANGALAM

img img img img
No Data Available

Experience smart and hassle-free investing in minutes with Bajaj Broking! *T&C apply

MANGALAM DRUG & CHEM LTD performance

Today’s low

Today’s high

₹ 77.10 ₹ 79.01
₹ 78.02

52 week low

52 week high

₹ 72.01 ₹ 144.99
₹ 78.02

Open Price

₹ 79.00

Prev. Close

₹ 78.04

Volume (Shares)

6293.00

Total traded value

₹ 4.90

Upper Circuit

₹ 93.64

Lower Circuit

₹ 62.43

info

MANGALAM DRUG & CHEM LTD Share Price Update

As of the latest trading session, MANGALAM DRUG & CHEM LTD share price is currently at ₹ 78.9, which is up by ₹ 0.86 from its previous closing. Today, the stock has fluctuated between ₹ 77.10 and ₹ 79.01. Over the past year, MANGALAM DRUG & CHEM LTD has achieved a return of -23.39 %. In the last month alone, the return has been -0.85 %. Read More...

MANGALAM DRUG & CHEM LTD fundamentals


  • Market cap (Cr)

    124.88

  • P/E Ratio (TTM)

    11.92

  • Beta

    0.94

  • Book Value / share

    93.14

  • Return on equity

    -6.15%

  • EPS (TTM)

    6.52

  • Dividend yield

    0.00%

  • Net profit/quarter (Cr)

    1.40

info icon alternate text
  • Market cap (Cr)

    122.96

  • P/E Ratio (TTM)

    11.92

  • Beta

    0.98

  • Book Value / share

    93.14

  • Return on equity

    -6.15%

  • EPS (TTM)

    6.52

  • Dividend yield

    0.00%

  • Net profit/quarter (Cr)

    1.40

info icon alternate text

MANGALAM DRUG & CHEM LTD Financials

  • Key Results

  • Key Ratios

  • Balance sheet

  • Cash Flow

  • Competition

info-icon

Revenue

Net income

Particulars DEC 2024 (Values in Cr)
Revenue 88.55
Operating Expense 87.36
Net Profit 1.40
Net Profit Margin (%) 1.58
Earnings Per Share (EPS) 0.89
EBITDA 8.90
Effective Tax Rate (%) 5.40
Particulars SEP 2024 (Values in Cr)
Revenue 79.75
Operating Expense 78.89
Net Profit 2.69
Net Profit Margin (%) 3.37
Earnings Per Share (EPS) 1.70
EBITDA 8.84
Effective Tax Rate (%) -124.16
Particulars JUN 2024 (Values in Cr)
Revenue 76.49
Operating Expense 75.97
Net Profit 2.68
Net Profit Margin (%) 3.50
Earnings Per Share (EPS) 1.70
EBITDA 8.20
Effective Tax Rate (%) -362.06
Particulars MAR 2024 (Values in Cr)
Revenue 101.94
Operating Expense 98.34
Net Profit 3.55
Net Profit Margin (%) 3.48
Earnings Per Share (EPS) 2.24
EBITDA 11.75
Effective Tax Rate (%) 9.89
Particulars DEC 2023 (Values in Cr)
Revenue 97.05
Operating Expense 97.29
Net Profit 0.50
Net Profit Margin (%) 0.51
Earnings Per Share (EPS) 0.32
EBITDA 6.97
Effective Tax Rate (%) -1150.00
Particulars MAR 2024 (Values in Cr)
Revenue 367.35
Operating Expense 379.75
Net Profit -9.05
Net Profit Margin (%) -2.46
Earnings Per Share (EPS) -5.72
EBITDA 17.49
Effective Tax Rate (%) 18.17
Particulars MAR 2023 (Values in Cr)
Revenue 370.20
Operating Expense 370.47
Net Profit 1.27
Net Profit Margin (%) 0.34
Earnings Per Share (EPS) 0.80
EBITDA 26.16
Effective Tax Rate (%) 42.53
Particulars MAR 2022 (Values in Cr)
Revenue 450.86
Operating Expense 423.42
Net Profit 19.66
Net Profit Margin (%) 4.36
Earnings Per Share (EPS) 12.42
EBITDA 49.14
Effective Tax Rate (%) 29.13
Particulars MAR 2021 (Values in Cr)
Revenue 379.98
Operating Expense 345.18
Net Profit 27.97
Net Profit Margin (%) 7.36
Earnings Per Share (EPS) 17.67
EBITDA 58.03
Effective Tax Rate (%) 29.22
Particulars MAR 2020 (Values in Cr)
Revenue 282.35
Operating Expense 277.28
Net Profit 8.25
Net Profit Margin (%) 2.92
Earnings Per Share (EPS) 5.21
EBITDA 24.86
Effective Tax Rate (%) -32.00
Particulars MAR 2024 (Values in Cr)
Book Value / Share 85.79
ROE % -6.68
ROCE % 1.16
Total Debt to Total Equity 0.78
EBITDA Margin 4.75
Particulars MAR 2024 (Values in Cr)
Book Value / Share 89.93
ROE % -6.15
ROCE % 1.16
Total Debt to Total Equity 0.66
EBITDA Margin 4.75
Particulars MAR 2023 (Values in Cr)
Book Value / Share 96.00
ROE % 0.84
ROCE % 6.25
Total Debt to Total Equity 0.58
EBITDA Margin 7.03
Particulars MAR 2022 (Values in Cr)
Book Value / Share 95.12
ROE % 13.98
ROCE % 17.57
Total Debt to Total Equity 0.56
EBITDA Margin 10.89
Particulars MAR 2021 (Values in Cr)
Book Value / Share 82.63
ROE % 23.83
ROCE % 27.41
Total Debt to Total Equity 0.52
EBITDA Margin 15.27
Particulars MAR 2020 (Values in Cr)
Book Value / Share 65.67
ROE % 8.27
ROCE % 10.51
Total Debt to Total Equity 0.59
EBITDA Margin 7.94
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 1.18
Total Assets 333.70
Total Liabilities 333.70
Total Equity 135.79
Share Outstanding 15828248
Price to Book Ratio 1.03
Return on Assets (%) -2.71
Return on Capital (%) -4.05
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 1.00
Total Assets 357.14
Total Liabilities 357.14
Total Equity 142.34
Share Outstanding 15828248
Price to Book Ratio 1.03
Return on Assets (%) -2.53
Return on Capital (%) -3.93
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 1.04
Total Assets 357.98
Total Liabilities 357.98
Total Equity 151.95
Share Outstanding 15828248
Price to Book Ratio 1.02
Return on Assets (%) 0.35
Return on Capital (%) 0.58
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 1.95
Total Assets 328.42
Total Liabilities 328.42
Total Equity 150.56
Share Outstanding 15828248
Price to Book Ratio 1.08
Return on Assets (%) 5.98
Return on Capital (%) 8.82
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 0.59
Total Assets 264.10
Total Liabilities 264.10
Total Equity 130.78
Share Outstanding 15828248
Price to Book Ratio 1.20
Return on Assets (%) 10.59
Return on Capital (%) 14.81
Particulars MAR 2020 (Values in Cr)
Cash & Short Term Investments 1.62
Total Assets 230.66
Total Liabilities 230.66
Total Equity 103.93
Share Outstanding 15828248
Price to Book Ratio 0.46
Return on Assets (%) 3.57
Return on Capital (%) 5.5
Particulars MAR 2024 (Values in Cr)
Net Income 3.97
Cash from Operations 4.00
Cash from Investing -11.82
Cash from Financing 5.22
Net change in Cash -2.68
Free Cash Flow 15.83
Particulars MAR 2024 (Values in Cr)
Net Income -11.05
Cash from Operations 12.35
Cash from Investing -17.90
Cash from Financing 5.69
Net change in Cash -0.03
Free Cash Flow 30.27
Particulars MAR 2023 (Values in Cr)
Net Income 2.21
Cash from Operations 38.05
Cash from Investing -22.17
Cash from Financing -16.82
Net change in Cash -0.91
Free Cash Flow 65.97
Particulars MAR 2022 (Values in Cr)
Net Income 27.73
Cash from Operations 34.51
Cash from Investing -27.32
Cash from Financing 2.97
Net change in Cash 1.36
Free Cash Flow 62.18
Particulars MAR 2021 (Values in Cr)
Net Income 39.51
Cash from Operations 36.81
Cash from Investing -31.28
Cash from Financing 2.69
Net change in Cash -1.03
Free Cash Flow 68.25
Particulars MAR 2020 (Values in Cr)
Net Income 6.25
Cash from Operations 30.60
Cash from Investing -6.87
Cash from Financing -23.47
Net change in Cash 0.19
Free Cash Flow 37.53
Company Name Price P/E P/B Market Cap 52 Week Low/High
AMBALAL SARABHAI ENTERPRISES L 36.46 19.60 1.99 279.41 34.11 / 77.70
BLISS GVS PHARMA LTD 119.00 15.60 1.24 1253.91 92.25 / 184.95
CIPLA LTD 1549.65 25.08 4.41 125155.99 1310.05 / 1702.00
FERMENTA BIOTECH LIMITED 260.70 21.60 2.64 767.27 145.00 / 449.00
Company Name Price P/E P/B Market Cap 52 Week Low/High

MANGALAM DRUG & CHEM LTD Technicals Summary

  • EMA & SMA
  • Resistance and Support
  • Delivery and Volume
  • Beta
  • Price Change Analysis
78.02 -0.02 redarrow
red-green-graph indicator
16 Bearish
0 Bullish
  • 5 Days 79.20
  • 26 Days 80.80
  • 10 Days 79.70
  • 50 Days 85.50
  • 12 Days 79.70
  • 100 Days 93.80
  • 20 Days 80.00
  • 200 Days 101.10
78.53 PIVOT

First Support

77.32

First Resistance

79.24

Second Support

76.61

Second Resistance

80.45

Third Support

75.40

Third Resistance

81.16

RSI

43.41

ADX

16.81

MACD

-1.12

Williams % R

-63.64

Commodity Channel Index (CCI)

-31.84

Date

2025-04-30

Week

11430.00

Same Day

3092.00

Month

14153.00

1 Year

0.95

3 Year

0.75

Over 1 Month

-0.85%

down

Over 1 Year

-23.39%

down

Over 3 Months

-24.11%

down

Over 3 Years

-12.37%

down

Over 6 Months

-30.05%

down

Over 5 Years

1.49%

down

Invest with Confidence

Left Arrow
MTF boost
Buy Now. Pay Later

Boost your capital upto 5 X

img
IPO boost
Invest in IPOs
They give good returns
img
Right Arrow

MANGALAM DRUG & CHEM LTD shareholding pattern

  • Shareholding Summary

  • Historical Promotor Holding

  • Historical MF Holding

  • Historical FII Holding

Holding

Others
49.23%
Promoter Holdings
50.3%
FII
0.46%
DII
0.0%
Promoter Shares(Pledge Percentage)
13.23%
Name Shares Category
Shri Jb Pharma Private Limited 2650000.0 (16.74%) Shareholding of Promoter and Promoter Group
Shree Kishoriju Trading And Investments Private Limited 1098515.0 (6.94%) Shareholding of Promoter and Promoter Group
Shree Rasbihari Trading And Investments Private Limited 1011663.0 (6.39%) Shareholding of Promoter and Promoter Group
Dhoot Govardhan Murlidhar 511792.0 (3.23%) Shareholding of Promoter and Promoter Group
Dhoot Brijmohan Murlidhar 486996.0 (3.08%) Shareholding of Promoter and Promoter Group
Shweta Govardhan Dhoot 410000.0 (2.59%) Shareholding of Promoter and Promoter Group
Ashutosh Tapria 302000.0 (1.91%) Public Shareholding
Smita A. Dhoot 292500.0 (1.85%) Shareholding of Promoter and Promoter Group
Radhika A. Dhoot 292500.0 (1.85%) Shareholding of Promoter and Promoter Group
Rajkumari R. Dhoot 275948.0 (1.74%) Shareholding of Promoter and Promoter Group
Jyotiprasad Taparia 211291.0 (1.33%) Public Shareholding
Raj Exports Private Limited 191520.0 (1.21%) Shareholding of Promoter and Promoter Group
Ambika Food Industries Private Limited 164979.0 (1.04%) Public Shareholding
Govardhan Murlidhar Dhoot 155330.0 (0.98%) Shareholding of Promoter and Promoter Group
Dhoot Rekha Govardhan 146760.0 (0.93%) Shareholding of Promoter and Promoter Group
Ajay R. Dhoot 138687.0 (0.88%) Shareholding of Promoter and Promoter Group
Dhoot Jyoti Brijmohan 104550.0 (0.66%) Shareholding of Promoter and Promoter Group
Aditya R. Dhoot 89225.0 (0.56%) Shareholding of Promoter and Promoter Group
Brijmohan Murlidhar Dhoot 77473.0 (0.49%) Shareholding of Promoter and Promoter Group
Rajkamal Sukhani 28520.0 (0.18%) Shareholding of Promoter and Promoter Group
Chandrakanta Murlidhar Dhoot 67.0 (0.0%) Shareholding of Promoter and Promoter Group

News

Left Arrow
Right Arrow

MANGALAM DRUG & CHEM LTD corporate actions

  • Dividend

  • Bonus

  • Split

Dividend date Dividend amount Dividend type Record date Instrument type
21 Dec 2017 0.5 Interim 22 Dec 2017 Equity shares
30 Aug 2005 0.0 Final 01 Sep 2005 Equity shares
Ex-Date Ex-Bonus Ratio
[-] [-] [-]
Ex-Date Old FV NEW FV Record Date
[-] [-] [-] [-]
  • Dividend

  • Bonus

  • Split

Dividend date Dividend amount Dividend type Record date Instrument type
21 Dec 2017 0.5 Interim 22 Dec 2017 Equity shares
30 Aug 2005 0.0 Final 01 Sep 2005 Equity shares
Ex-Date Ex-Bonus Ratio
[-] [-] [-]
Ex-Date Old FV NEW FV Record Date
[-] [-] [-] [-]

MANGALAM DRUG & CHEM LTD Share Price

Mangalam Drugs and Organics Ltd was formerly incorporated on April 18, 1972 as a private limited company with the name Advent Pharma Pvt Ltd. On July 1, 1997, the Company changed their name from Advent Pharma Pvt Ltd to Mangalam Drugs and Organics Pvt Ltd.
Thereafter, the Company converted into a Public Limited Company and name of the Company was changed from Advent Pharma Ltd to Mangalam Drugs and Organics Ltd on August 10, 2001. The company was promoted by Dhoot family. The company was established with a view to set up a plant for manufacture of organic and inorganic chemicals.

The company is engaged in the manufacturing of chemicals, such as active pharma ingredients (API) perfumery, disperse dye intermediates, bulk drugs and bulk drugs intermediates. The company has their manufacturing facilities at Vapi in Gujarat and Sangamner in Maharashtra. They also have an in-house Research and Development (R&D) Base. Their products include chloroquine phosphate I.P., aluminum chloride anhydrous, and dyes and intermediaries.

In April 1, 1996 three other group companies, namely Mangalam Organics Pvt Ltd, Shree Mangalam Pharma Pvt Ltd and Mangalam Rasayan Pvt Ltd were amalgamated with the company.

In the year 1999, the company launched a new product namely, Nimesulide. In the year 2001, they launched two new products namely Amodiaquine Hydrochloride and Amodiaquine.

In the year 2003-2004, the bulk drug production capacity of the Company was increased from 350 MTPA to 600 MTPA. During the 2004-05, the capacity is being further enhanced to 960 MTPA. During the year 2005-06, the company further enhanced their Bulk drug production capacity from 960 MT per annum to 1260 MT per annum.

During the year 2007-08, the company developed and introduced new bulk drugs namely Bisoprolol Fumarate and Pantaprazole Sodium. Also, they increased the production capacity of Meta Chloro Aniline & Allied Products from 250 tons to 350 tons.

During the year 2009-10, the company in addition to Regulatory Affairs Cell established Intellectual Property Rights (IPR) cell. The regulatory affairs cell submitted 6 DMFs to WHO-Geneva out of which 2 DMFs corresponding to Artemether and Lumefantrine had been approved.

During the year 2017-18, Unit 2 of the Company received WHO Approvals for manufacturing of the Active Pharmaceutical ingredients comprising of Lumefantrine (APIMF100); Tenofovir Disoproxil Fumarate (APIMF204); Artemether (APIMF138); Emtricitabine (WHO API314); Efavirenz (WHO API 318).

Parent organization Indian Private
NSE symbol MANGALAM
Founded 1972
stock

Trade stocks with ease

Sign-in to trade with your demat account, or set up a new demat account for free

Board Of Directors

Left Arrow
Right Arrow

Similar stocks

Left Arrow
Right Arrow

Frequently Asked Questions

What is the Share Price of Mangalam Drugs and Organics Ltd?

Answer Field

The share price of Mangalam Drugs and Organics Ltd for NSE is ₹ 78.9 and for BSE is ₹ 77.69.

What is the Market Cap of Mangalam Drugs and Organics Ltd?

Answer Field

The market cap of Mangalam Drugs and Organics Ltd for NSE is ₹ 1,24.88 Cr. and for BSE is ₹ 1,22.96 Cr. as of now.

What is the 52 Week High and Low of Mangalam Drugs and Organics Ltd?

Answer Field

The 52 Week High and Low of Mangalam Drugs and Organics Ltd for NSE is ₹ 144.99 and ₹ 72.01 and for BSE is ₹ 144.65 and ₹ 70.11.

How to Buy Mangalam Drugs and Organics Ltd share?

Answer Field

You can trade in Mangalam Drugs and Organics Ltd shares with Bajaj Broking by opening a Demat Account.

What is 1 year return for Mangalam Drugs and Organics Ltd?

Answer Field

The 1 year returns on the stock has been -23.39%.

What is the Current Share Price of Mangalam Drugs and Organics Ltd?

Answer Field

Mangalam Drugs and Organics Ltd share price is for NSE ₹ 78.9 & for BSE ₹ 77.69 as on Apr 30 2025 03:29 PM.

What is the Market Cap of Mangalam Drugs and Organics Ltd Share?

Answer Field

The market cap of Mangalam Drugs and Organics Ltd for NSE ₹ 1,24.88 & for BSE ₹ 1,22.96 as on Apr 30 2025 03:29 PM.

What is the P/E Ratio of Mangalam Drugs and Organics Ltd Share?

Answer Field

As on Apr 30 2025 03:29 PM the price-to-earnings (PE) ratio for Mangalam Drugs and Organics Ltd share is 11.92.

What is the PB ratio of Mangalam Drugs and Organics Ltd Share?

Answer Field

As on Apr 30 2025 03:29 PM, the price-to-book (PB) ratio for Mangalam Drugs and Organics Ltd share is 93.14.

How to Buy Mangalam Drugs and Organics Ltd Share?

Answer Field

You can trade in Mangalam Drugs and Organics Ltd shares with Bajaj Broking by opening a demat account.

How to Buy Mangalam Drugs and Organics Ltd Share on Bajaj Broking App?

Answer Field

To buy Mangalam Drugs and Organics Ltd shares on the Bajaj Broking app, follow these steps:

• Login to the Bajaj Broking App

• Click on the Search Icon

• Search “Mangalam Drugs and Organics Ltd”

• Click on the BUY icon

• Place a buy order specifying the desired quantity of shares.

• Click BUY again to complete the purchase

No results found

banner-icon

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|

Please Enter Mobile Number

Open Your Free Demat Account

Enjoy low brokerage on delivery trades

+91

|